Cargando…
The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane
Lipophilic weak base therapeutic agents, termed lysosomotropic drugs (LDs), undergo marked sequestration and concentration within lysosomes, hence altering lysosomal functions. This lysosomal drug entrapment has been described as luminal drug compartmentalization. Consistent with our recent finding...
Autores principales: | Stark, Michal, Silva, Tomás F. D., Levin, Guy, Machuqueiro, Miguel, Assaraf, Yehuda G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290590/ https://www.ncbi.nlm.nih.gov/pubmed/32349204 http://dx.doi.org/10.3390/cells9051082 |
Ejemplares similares
-
Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity
por: Zhitomirsky, Benny, et al.
Publicado: (2018) -
Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2014) -
Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2022) -
Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
por: Zhitomirsky, Benny, et al.
Publicado: (2017) -
Lysosomal adaptation: How cells respond to lysosomotropic compounds
por: Lu, Shuyan, et al.
Publicado: (2017)